Butler John P.
CEO and President
Butler John P. has filed 4 SEC Form 4 filings (8 transaction rows) across 1 company, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Aug 10, 2026.
On the most recent filing, Butler John P. is listed as CEO and President at Akebia Therapeutics, Inc. Inside the rolling window, Butler John P. reported 1 open-market purchase totaling $87K in AKBA and 1 open-market sale totaling $474K in AKBA. The largest disclosed transaction in the window is a sale of 341,305 AKBA shares on Feb 2, 2026, worth $474K.
Companies traded
Other insiders at AKBA
Insider Buying
$87K
reported purchases (SEC code P)
Insider Selling
$474K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Butler John P. made?
Butler John P. has filed 4 SEC Form 4 filings (8 transaction rows) across 1 company since 2026.
Which companies does Butler John P. trade?
Butler John P. has filed SEC Form 4 disclosures for 1 company, including AKBA.
When was Butler John P.'s most recent SEC Form 4 filing?
Butler John P.'s most recent SEC Form 4 filing on Tracefour is dated Aug 10, 2026.
What is Butler John P.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Butler John P. is listed as CEO and President.
What is Butler John P.'s total buy and sell value in the current window?
Inside the rolling retention window, Butler John P. bought $87K and sold $474K based on SEC Form 4 filings.
What was Butler John P.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 341,305 AKBA shares on 2026-02-02, worth $474K, per SEC Form 4 filings.